These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10987272)

  • 1. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.
    Chulada PC; Thompson MB; Mahler JF; Doyle CM; Gaul BW; Lee C; Tiano HF; Morham SG; Smithies O; Langenbach R
    Cancer Res; 2000 Sep; 60(17):4705-8. PubMed ID: 10987272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis.
    Tiano HF; Loftin CD; Akunda J; Lee CA; Spalding J; Sessoms A; Dunson DB; Rogan EG; Morham SG; Smart RC; Langenbach R
    Cancer Res; 2002 Jun; 62(12):3395-401. PubMed ID: 12067981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice.
    Kitamura T; Itoh M; Noda T; Matsuura M; Wakabayashi K
    Int J Cancer; 2004 Apr; 109(4):576-80. PubMed ID: 14991580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.
    Zhang X; Morham SG; Langenbach R; Young DA; Xing L; Boyce BF; Puzas EJ; Rosier RN; O'Keefe RJ; Schwarz EM
    J Bone Miner Res; 2001 Apr; 16(4):660-70. PubMed ID: 11315993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
    Shattuck-Brandt RL; Lamps LW; Heppner Goss KJ; DuBois RN; Matrisian LM
    Mol Carcinog; 1999 Mar; 24(3):177-87. PubMed ID: 10204802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cyclooxygenases in inflammation, cancer, and development.
    Williams CS; Mann M; DuBois RN
    Oncogene; 1999 Dec; 18(55):7908-16. PubMed ID: 10630643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COX-2 inhibitor NS-398 causes T-cell developmental disruptions independent of COX-2 enzyme inhibition.
    Xu H; Izon DJ; Loftin C; Spain LM
    Cell Immunol; 2001 Dec; 214(2):184-93. PubMed ID: 12088417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps.
    Sonoshita M; Takaku K; Oshima M; Sugihara K; Taketo MM
    Cancer Res; 2002 Dec; 62(23):6846-9. PubMed ID: 12460897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice.
    Sonoshita M; Takaku K; Sasaki N; Sugimoto Y; Ushikubi F; Narumiya S; Oshima M; Taketo MM
    Nat Med; 2001 Sep; 7(9):1048-51. PubMed ID: 11533709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice.
    Hull MA; Booth JK; Tisbury A; Scott N; Bonifer C; Markham AF; Coletta PL
    Br J Cancer; 1999 Mar; 79(9-10):1399-405. PubMed ID: 10188882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2.
    Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps.
    Seno H; Oshima M; Ishikawa TO; Oshima H; Takaku K; Chiba T; Narumiya S; Taketo MM
    Cancer Res; 2002 Jan; 62(2):506-11. PubMed ID: 11809702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of intestinal polyposis by inhibition of COX-2 in Apc knockout mice.
    Vane J
    Jpn J Cancer Res; 1997 Nov; 88(11):inside front cover. PubMed ID: 9439674
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
    Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors.
    Pentland AP; Scott G; VanBuskirk J; Tanck C; LaRossa G; Brouxhon S
    Cancer Res; 2004 Aug; 64(16):5587-91. PubMed ID: 15313895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus.
    Carlton PS; Gopalakrishnan R; Gupta A; Liston BW; Habib S; Morse MA; Stoner GD
    Cancer Res; 2002 Aug; 62(15):4376-82. PubMed ID: 12154043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.